Recurrent Liver Carcinoma Recruiting Phase 2 Trials for AZD-4547 (DB12247)

IndicationStatusPhase
DBCOND0081575 (Recurrent Liver Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs